54 /100
HIGH RISK
Score updated Apr 13, 2026

APRE

Aprea Therapeutics, Inc. — Stock Dilution Tracker

Track APRE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track APRE — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
90
💰 Cash Runway
25
📊 Float Risk
27
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
33%
🔄 Reverse Split 55%
• 50-day avg $0.75 below $1 exchange minimum
💰 Capital Raise 20%
• Active shelf registration ($400M, 3810% of market cap)
🔔 Track APRE — Get forecast alerts →
💹 Market Data
Market Cap$10.50M
Shares Outstanding11.45M
Float8.78M
Cash$14.60M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 1.58M shares
#1 AIGH Capital Management LLC 370.5K shares
#2 Murchinson Ltd. 340.1K shares
#3 Sphera Funds Management Ltd. 270.0K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest640.3K
Days to Cover1.0
% of Float7.3%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
4 INSIDER TRANSACTION Apr 01, 2026
4 INSIDER TRANSACTION Apr 01, 2026
8-K 8K EVENT Apr 01, 2026
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track APRE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking APRE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required